| Added by | mollevi |
|---|---|
| Last modified by | Nathalie Bonnefoy |
| Group name | EquipeNB |
| Item Type | Journal Article |
| Title | Lymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis |
| Creator | Bastid et al. |
| Author | J. Bastid |
| Author | N. Bonnefoy |
| Author | J. F. Eliaou |
| Author | A. Bensussan |
| Abstract | We have previously reported that a subset of breast tumors are infiltrated with IL-17A-producing tumor-associated lymphocytes and that IL-17A cytokine is principally associated with estrogen receptor negative (ER-) and triple negative, basal-like tumors. We established that IL-17A producing lymphocytes induced cancer cell proliferation, chemoresistance, and invasion, indicating that IL-17A is a potential therapeutic target for breast malignancies. |
| Publication | Oncoimmunology |
| Volume | 3 |
| Pages | e28273 |
| Date | 2014 |
| Journal Abbr | Oncoimmunology |
| DOI | 10.4161/onci.28273 |
| ISSN | 2162-4011 (Print) |
| Tags | review |
| Date Added | 2018/11/14 - 12:04:32 |
| Date Modified | 2019/05/28 - 22:41:08 |
| Notes and Attachments | (Note) (Note) 25050201 (Attachment) |
Institut de Recherche en Cancérologie de
